RNAi inhibition of mineralocorticoid receptors prevents the development of cold-induced hypertension

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 294, Issue 4, 2008, Pages

  Sun, Zhongjie ^a,b   Bello Roufai, Mahajoub ^b   Wang, Xiuqing ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Adeno associated virus; Aldosterone; Blood pressure; Cardiac hypertrophy; RNA interference; Short hairpin RNA

Indexed keywords

ALDOSTERONE; MINERALOCORTICOID RECEPTOR; RENIN; SHORT HAIRPIN RNA;

ADENO ASSOCIATED VIRUS; ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; COLD EXPOSURE; CONTROLLED STUDY; HEART HYPERTROPHY; HYPERTENSION; MALE; MOUSE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; VIRUS RECOMBINANT;

ALDOSTERONE; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; CARDIOMEGALY; COLD; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DRINKING; EATING; GENE THERAPY; GENETIC VECTORS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; MICE; NOREPINEPHRINE; RECEPTORS, MINERALOCORTICOID; RENIN; RNA INTERFERENCE; RNA, SMALL INTERFERING; TIME FACTORS; TRANSDUCTION, GENETIC; URINATION; VIRAL PROTEINS;

EID: 41749090701     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01319.2007     Document Type: Article

References (43)

1. Baker-Blocker A. Winter weather and cardiovascular mortality in Minneapolis-St. Paul. Am J Public Health 72: 261-265, 1982.
2. Blasi ER, Rocha R, Rudolph AE, Blomme EAG, Polly ML, McMahon EG. Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int 63: 1791-1800, 2003.
3. Caicoya M, Rodriguez T, Lasheras C, Cuello R, Corrales C, Blazquez T. Stroke incidence in Asturias, 1990-1991. Rev Neurol 24: 806-811, 1996.
4. Donaldson GC, Robinson D, Allaway SL. An analysis of arterial disease mortality and BUPA health screening data in men, in relation to outdoor temperature. Clin Sci (Colch) 92: 261-268, 1997.
5. Fregly MJ, Kikta DC, Threatte RM, Torres JL, Barney CC. Development of hypertension in rats during chronic exposure to cold. J Appl Physiol 66: 741-749, 1989.
6. Gyllerup S, Lnke J, Lindholm LH, Schersten B. Cold climate is an important factor in explaining regional differences in coronary mortality even if serum cholesterol and other established risk factors are taken into account. Scott Med J 38: 169-172, 1993.
7. Hata T, Ogihara T, Maruyama H, Mikami H, Nakamaru M, Naka T. The seasonal variation of blood pressure in patients with essential hypertension. Clin Exp Hypertens A 4: 341-354, 1982.
8. + channels prevents sympathetic hyperactivity and improves cardiac function in rats post-MI. Am J Physiol Heart Circ Physiol 288: H2491-H2497, 2005.
9. Kim JY, Jung KY, Hong YS, Kim JI, Jang TW, Kim JM. The relationship between cold exposure and hypertension. J Occup Health 45: 300-306, 2003.
10. Kobayashi N, Hara K, Tojo A, Onozato ML, Honda T, Yoshida K. Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKCepsilon-MAPK-p90RSK, and Rho-kinase pathway. Hypertension 45: 538-544, 2005.
11. Marchant B, Ranjadayalan K, Stevenson R, Wilkinson P, Timmis AD. Circadian and seasonal factors in the pathogenesis of acute myocardial infarction: the influence of environmental temperature. Br Heart J 69: 385-387, 1993.
12. Micromedex. Eplerenone Drug Evaluation. Monograph, vol. 114, 1972-1974 (Exp. 12/12/2002).
13. Minami J, Kawano Y, Ishimitsu T, Yoshimi H, Takisita S. Seasonal variations in office, home and 24 h ambulatory blood pressure in patients with essential hypertension. J Hypertens 14: 1421-1425, 1996.
14. Nagata K, Obata K, Xu J, Ichihara S, Noda A, Kimata H. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats. Hypertension 47: 656-664, 2006.
15. Ortiz RM, Graciano ML, Seth Dale Awayda MS, Navar GL. Aldosterone receptor antagonism exacerbates intrarenal angiotensin II augmentation in ANG II-dependent hypertension. Am J Physiol Renal Physiol 293: F139-F147, 2007.
16. Park JB, Schiffrin EL. Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1. Am J Hypertens 15: 164-169, 2002.
17. Peng JF, Kimura B, Fregly MJ, Phillips MI. Reduction of cold-induced hypertension by antisense oligodeoxynucleotides to angiotensinogen mRNA and AT1-receptor mRNA in brain and blood. Hypertension 31: 1317-1323, 1998.
18. Phillips MI. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension. Hypertension 29: 177-187, 1997.
19. Phillips MI. Gene therapy for hypertension: the preclinical data. Hypertension 38: 543-549, 2001.
20. Phillips MI, Tang Y, Schmidt-Ott K, Qian K, Kagiyama S. Vigilant vector: heart-specific promoter in an adeno-associated virus vector for cardioprotection. Hypertension 39: 651-655, 2002.
21. Rafestin-Oblin ME, Claire M, Michaud A, Corvol T. Mineralocorticoid receptors during normal kidney growth and compensatory renal hypertrophy. J Steroid Biochem 14: 337-340, 1981.
22. Rahmouni K, Barthelmebs M, Grima M, Imbs JL, De Jong W. Brain mineralocorticoid receptor control of blood pressure and kidney function in normotensive rats. Hypertension 33: 1201-1206, 1999.
23. Rohr UP, Wulf MA, Stahn S, Steidl U, Haas R, Kronenwett R. Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR. J Virol Methods 106: 81-88, 2002.
24. Seretakis D, Lagiou P, Lipworth L, Signorello LB, Rothman KJ, Trichopoulos D. Changing seasonality of mortality from coronary heart disease. JAMA 278: 1012-1014, 1997.
25. Sheth T, Nair C, Muller J, Yusuf S. Increased winter mortality from acute myocardial infarction and stroke: the effect of age. J Am Coll Cardiol 33: 1916-1919, 1999.
26. Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, Weber KT. Aldosterone-induced inflammation in the rat heart: role of oxidative stress. Am J Pathol 161: 1773-1781, 2002.
27. Sun Z, Cade JR, Fregly MJ. Cold-induced hypertension: a model of mineralocorticoid-induced hypertension. Ann NY Acad Sci 813: 682-688, 2002.
28. Sun Z, Cade R, Zhang Z, Alouidor J, Van H. Angiotensinogen gene knockout delays and attenuates cold-induced hypertension. Hypertension 41: 322-327, 2003.
29. Sun Z, Zhang Z. Historic perspectives and recent advances in major animal models of hypertension. Acta Pharmacol Sin 26: 295-301, 2005.
30. Sun Z, Cade R, Katovich MJ, Fregly MJ. Body fluid distribution in rats with cold-induced hypertension. Physiol Behav 65: 879-884, 1999.
31. Sun Z, Cade R, Tatum C. Central imidazoline and angiotensin II receptors in cardiovascular responses to chronic cold exposure in rats. J Therm Biol 26: 513-518, 2001.
32. Sun Z, Cade R, Morales C. Role of central angiotensin II receptors in cold-induced hypertension. Am J Hypertens 15: 85-92, 2002.
33. Sun Z, Fregly MJ, Cade JR. Effect of renal denervation on elevation of blood pressure in cold-exposed rats. Can J Physiol Pharmacol 73: 72-78, 1995.
34. 1A receptor deficiency attenuates cold-induced hypertension. Am J Physiol Regul Integr Comp Physiol 288: R433-R439, 2005.
35. Sun Z. Genetic AVP deficiency abolishes cold-induced diuresis but does not attenuate cold-induced hypertension. Am J Physiol Renal Physiol 290: F1472-F1477, 2006.
36. Thorvaldsen P, Asplund K, Kuulasmma AM, Schroll M. Stroke incidence, case fatality, and mortality in the WHO MONICA project: world health organization monitoring trends and determinants in cardiovascular diseases. Stroke 26: 361-367, 1995.
37. Verdon F, Boudry F, Chuat M, Studer JP, Truong CN, Jacot E. Seasonal variations in arterial blood pressure in hypertensive patients. Schweiz Med Wochenschr 123: 2363-2369, 1993.
38. Wang X, Cade R, Sun Z. Human eNOS gene delivery attenuates cold-induced hypertension. Am J Physiol Heart Circ Physiol 289: H1161-H1168, 2005.
39. Wang X, Sun Z, Cade R. Prolonged attenuation of cold-induced hypertension by adenoviral delivery of renin antisense. Kidney Int 68: 680-687, 2005.
40. Wang X, Skelley L, Sun Z. AAV delivery of mineralocorticoid receptor shRNA prevents progression of cold-induced hypertension and attenuates renal damage. Gene Ther 13: 1097-1103, 2006.
41. Wang X, Sun Z, Cade R. Prolonged attenuation of cold-induced hypertension by adenoviral delivery of renin antisense. Kidney Int 68: 680-687, 2005.
42. Zhai Y, Pai HV, Zhou J, Amico JA, Vollmer RR, Xie W. Activation of pregnane X receptor disrupts glucocorticoid and mineralocorticoid homeostasis. Mol Endocrinol 21: 138-147, 2007.
43. Zhu Z, Zhu S, Zhu J, van der Giet M, Tepel M. Endothelial dysfunction in cold-induced hypertensive rats. Am J Hypertens 15: 176-180, 2002.